T
Market Data
$30.32−$4.26 (−12.32%)
TVTX · Last trade
Prev Close
$34.58
Range (29d)
$27.87 – $34.10
Recent Filings
- 8-K161.5 KBTravere Therapeutics, Inc.Jan 13, 4:32 PM ET·0001438533-26-000005
- 8-K222.5 KBTravere Therapeutics, Inc.Jan 12, 5:04 PM ET·0001438533-26-000003
- 10-Q9.1 MBTravere Therapeutics, Inc.Oct 30, 4:46 PM ET·0001438533-25-000056
- 8-K426.4 KBTravere Therapeutics, Inc.Oct 30, 4:06 PM ET·0001438533-25-000055
- 8-K161.6 KBTravere Therapeutics, Inc.Sep 10, 7:05 AM ET·0001438533-25-000049
- 10-Q9.0 MBTravere Therapeutics, Inc.Aug 6, 5:16 PM ET·0001438533-25-000046
- 8-K418.1 KBTravere Therapeutics, Inc.Aug 6, 4:06 PM ET·0001438533-25-000045
- 8-K440.8 KBTravere Therapeutics, Inc.May 16, 4:13 PM ET·0001438533-25-000034
- 8-K168.9 KBTravere Therapeutics, Inc.May 15, 4:29 PM ET·0001438533-25-000032
- 8-K/A378.5 KBTravere Therapeutics, Inc.May 1, 5:21 PM ET·0001438533-25-000030
Insiders
10- ASELAGE STEVEDirector
- Baynes Roy D.Director
- Broadfin Capital, LLC10% Owner
- Broadfin Healthcare Master Fund Ltd10% Owner
- Bruhn Suzanne LouiseDirector
- Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
- Clague LauraChief Financial Officer
- Cline Christopher R.CHIEF FINANCIAL OFFICER
- Coughlin TimothyDirector
- Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
Tickers
Addresses
business
3611 VALLEY CENTRE DR SUITE 300
SAN DIEGO, CA, 92130
mailing
3611 VALLEY CENTRE DR SUITE 300
SAN DIEGO, CA, 92130
Former Names
- Retrophin, Inc.2020-11-13
- Desert Gateway, Inc.2013-02-19